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Abstract
Background: Commercially available fibrin is routinely being used as both a matrix in certain cartilage repair
techniques and a method for scaffold fixation. Chondrocytes from non-digested particulated cartilage fragments
are proposed as a possible source for new cartilage tissue formation in some operative techniques. The goal of
this study was to test that chondrocytes from particulated articular cartilage embedded in fibrin have an active
role in the process of cartilage repair, as well as if commercially available fibrin should be used as a suitable matrix.
Methods: Articular cartilage was obtained from patients undergoing total knee replacement surgery. The biopsies
were particulated in small, 1–2-mm3 pieces and embedded in fibrin. Two groups were compared in our study,
particulated articular cartilage with and without collagenase treatment. The specimens were analyzed by optical
microscopy after 2–5 weeks of cultivation in a special construct embedded in a cell culture medium containing
particulated cartilage embedded in fibrin in the upper phase and cancellous bone in the lower phase under the
perforated nylon membrane.
Results: None of the biopsies taken from four different patients showed the outgrowth of chondrocytes or bone
marrow-originated cells into the fibrin matrix in our experimental model.
Conclusions: It has been shown in our experimental model in vitro little to support the theory that articular
chondrocytes from particulated articular cartilage embedded in fibrin have an active role in cartilage repair in
its early stage.
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Background
A novel technique based on particulated cartilage em-
bedded in a suitable carrier, fibrin matrix among others,
has been recently introduced as an alternative treatment
in cartilage repair. Basically, there are two different variants
of the same technique: one using autologous articular
cartilage fragments and the other cartilage fragments
from juvenile allograft donor. These techniques are
known as the Cartilage Autograft Implantation System
(CAIS; DePuy/Mitek, Raynham, MA) and DeNovo Natural
Tissue (NT; ISTO, St. Louis, MO) [1, 2].
The authors have reported that in laboratory and
animal models, both techniques have shown the ability
of transplanted cartilage cells to migrate from an
extracellular matrix, divide, and form a new hyaline-like
cartilage tissue matrix that integrates with the surrounding
host tissue [2]. In another method for cartilage repair,
namely, autologous chondrocyte implantation (ACI), it
has been postulated that cartilage pieces have to be first
treated with enzymes, i.e., collagenase, in order to “release”
chondrocytes from the matrix, which can then migrate,
multiply, and eventually create a new cartilage-like tissue
formation [3].
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The goal of this study was to test if chondrocytes are
able to “escape” the cartilage without enzymatic diges-
tion and, by doing so, may have an active role in new
cartilage tissue formation, as well as if fibrin can be used
as a suitable matrix in cartilage repair techniques.
Methods
Cartilage and cancellous bone biopsies were obtained from
four patients undergoing total knee replacement surgery.
These patients had predominantly medial gonarthrosis,
and consequently, a macroscopically normal cartilage, as
judged by the surgeon, could be found in the lateral com-
partment of the knee. The cartilage biopsies were placed
in a sterile 12-ml tube on 37 °C and in a matter of hours
transferred to Dulbecco’s Modified Eagle’s Medium/Nutri-
ent Mixture F-12 Ham (Cat. Nr. D8437, Sigma-Aldrich).
Prior to that, amphotericin B and gentamicin were added
to the medium in final concentrations of 2.5 and 50 μg/ml,
respectively. The cartilage biopsies were minced to 1–2-
mm3 pieces. Approximately half of this cartilage was trans-
ferred to another sterile 12-ml tube containing collagenase
diluted in a cell culture medium to a total concentration of
0.8 mg/ml (collagenase type XI, C-9407, Sigma-Aldrich).
The rest of the cartilage fragments were left in the tube
with the cell culture medium alone, and both were then
placed into a cell incubator (37 °C and 5 % CO2) overnight.
The cancellous bone biopsies were placed in a sterile
24-well plate containing the cell culture medium with
added antibiotics and then left in the cell incubator
overnight.
After 18–24 h of incubation, cartilage fragments
digested in collagenase solution were washed two times
by centrifuge at 1250 rpm and during 10 min. During
the first wash, they were resuspended in a cell culture
medium containing 10 % human sterile-filtered serum,
second time without it. The final pellet was then placed
in a special insert containing 8-μm PET or 1.2-μm nylon
membrane (Fig. 1; CellCrown™24, Cat. Nr. C70001F,
C12001F, Scaffdex, Tampere, Finland) perforated with a
sterile 0.6 × 25-mm needle. The fibrin matrix (TISSEEL
DUO QUICK, Baxter, Sweden) was then added covering
in total cartilage fragments, and the inserts were placed
onto the top of the cancellous bone biopsies previously
situated in a sterile 24-well plate. The bone chips were
prior to that resuspended in 1–1.5-ml growth medium
containing 20 % human sterile-filtered serum. The whole
construct was at last embedded in a growth medium by
adding an extra medium onto the top of the insert. The
cell culture medium was regularly changed, and the growth
medium was replaced by a medium containing 10 % hu-
man sterile-filtered serum after 1 week of cultivation. After
2 weeks, the bone chips were removed from the wells. The
inserts containing particulated cartilage embedded in fibrin
were incubated during 2–5 weeks in total and then fixated
in 4 % paraformaldehyde. Subsequently, they were embed-
ded in paraffin and, when appropriate, ready to be analyze
by optical microscopy. Eosin and trichrome staining were
performed according to standard protocol as well as
immunohistochemistry with S-100, a specific chondrocyte
marker.
Ethical approvals and informed consents
The Regional Ethical Review Board in Uppsala, at
Uppsala Universitet has approved the study, and informed
consent was obtained from all the patients donating their
cartilage specimens for the study.
Results
We did not see the outgrowth of chondrocytes or pene-
tration into the fibrin matrix in none of the biopsies
taken from four different patients, not even after 5 weeks
of cultivation (Fig. 2). In addition to that, the biopsies
from samples treated with collagenase did show the out-
growth of chondrocytes but no invasion into the fibrin
matrix (Fig. 3). The presence of chondrocytes was de-
tected by S-100 (Fig. 4a, b). All other cells not stained
with S-100 antibodies were assumed to have their origin
from the bone marrow. The fibrin matrix showed poor
integration with cartilage fragments (Fig. 2). No cell ele-
ments were noticed in the fibrin matrix, and therefore,
no staining in fibrin for connective tissue with trichrome
was found (Fig. 2). The cells that originated from the
cancellous bone did migrate towards and through the
membrane but did not penetrate further on into the fibrin
matrix. On the contrary, they made a thin layer of cells on
Fig. 1 CellCrown™24 construct. With the courtesy of Scaffdex,
Tampere, Finland
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the upper side of the membrane and bellow the fibrin
matrix (Fig. 5).
Discussion
In our experimental model in vitro, we have seen the
outgrowth of articular chondrocytes only in those
specimens which have been digested with collagenase.
The articular chondrocytes from the particulated, but
non-digested, cartilage fragments have not shown any
tendency for outgrowth. This finding is quite opposite to
the claim of some other authors, namely, the establishers
of the abovementioned novel operative technique/s [2].
According to these authors, the ability of articular
chondrocytes to “escape” a cartilage has been proven
in both laboratory and animal models [2]. The enzymatic
digestion of the cartilage with collagenase has been postu-
lated as absolutely necessary for the migration of articular
chondrocytes out of the cartilage and their multiplication,
as done in ACI [3]. A study showing goat articular
chondrocyte outgrowth both in vitro and in vivo has
been done [4]. The presence of chondrocyte outgrowth
in vitro has been evident after 15 days and increased at
1 and 2 months. The cartilage fragments in this study
have been embedded in fibrin and loaded onto a scaffold
composed of a hyaluronic acid (HA)-derived membrane in
the lower phase and platelet-rich fibrin matrix (PRFM)
in the superior phase [4]. In our in vitro model, however,
the human articular chondrocytes remained captured
inside the fibrin matrix during the observed period of
time, 2–5 weeks namely (Fig. 2). We have used neither
HA-derived membrane nor PRFM, but still, it is a striking
fact that we have not identified a single chondrocyte es-
caping the cartilage matrix. When digesting the cartilage
fragments with collagenase overnight, the cells have es-
caped from the fragments, but a migration of cells into the
fibrin matrix has not been observed either (Fig. 3). It has
been suggested that a fibrin sealant promotes migration
and proliferation of human articular chondrocytes in vitro
[5]. On the other side, it has been reported that human fi-
brin glue hampered the healing process in rabbits in a
similar model to that previously described in the text [4,
6]. The difference between the first named study [5] and
our study is that we have used primary cartilage explants,
non-digested as well, while primary chondrocyte culture
has been used in the other case [5]. However, not even the
cancellous bone-derived cells have penetrated the fibrin
matrix, which speaks more in favor of fibrin-hampered
chondrocyte migration rather than fibrin sealant promo-
tion of cell migration as it has been described in the study
mentioned above [5]. Human mesenchymal stem cells
(hMSCs) have been used for the repair of osteochondral
defects in rabbits by seeding them on biphasic composite
constructs (hydroxyapatite + platelet-rich fibrin glue) for 4
and 8 weeks, respectively [7]. It has been postulated in this
study that the group where differentiated hMSCs have
been used has shown superior healing of osteochondral
defects first after 8 weeks [7]. In vivo, fibrin will be
gradually degraded during wound healing by fibrinolysis
and replaced by the mature extracellular matrix, wherein
the proteolytic activity of a membrane-type matrix
metalloproteinases (MT1-MMP) [8, 9] and plasmin
[10, 11] locally degrades the fibrin matrix. In vivo, this
happens in a matter of days or weeks, and the rate of
degradation depends on many factors such as fibrin struc-
ture, its cross-linking, and the incorporation of protease
Fig. 2 Particulated cartilage (in blue) embedded in fibrin matrix
(in violet), ×10 magnification. Trichrome staining is not showing
any presence of connective tissue in fibrin matrix (marked with
four-point stars). Chondrocytes (marked with arrow) are located
in the lacunas; there is no sign of cell migration into the matrix
after 5 weeks of cultivation
Fig. 3 Particulated cartilage (to the left and in the middle) digested
overnight with collagenase solution and thereafter embedded in
fibrin matrix (upper right corner), ×10 magnification. Some of the
cells (marked with arrow) have escaped cartilage matrix, but none of
them have penetrated into the fibrin matrix (marked with four-point
stars) after 5 weeks of cultivation. No staining for connective tissue
with trichrome has been detected inside the fibrin matrix
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inhibitors [12–15]. Generally, the fibrin matrix is gradually
replaced by mature collagen that is produced by invading
cells [16–18]. In our study in vitro, there is a lack of such
endogenous factors participating in the process of fibrin-
olysis, and one could therefore speculate that no invading
cells have been found in the fibrin matrix. The insufficient
degradation of fibrin and therefore scarce cell invasion
could be the reason why no significant healing have been
found after 4 weeks but first after 8 weeks as mentioned in
the previously named study [5]. Fibrin is gradually de-
graded in vivo as it was already explained in the text, and
the healing process succeeds its degradation, leading to
the new tissue formation eventually. The initial inhibition
of cell invasion and therefore new tissue formation that
we have seen in our in vitro model have therefore prob-
ably no effect on the final clinical outcome. Indeed, the au-
thors of this text have used routinely the fibrin matrix in
our cartilage repair techniques and have seen neither poor
defect fill nor poor clinical results that could be related to
the use of the fibrin matrix [19, 20].
We have not seen as well in our in vitro study that ar-
ticular chondrocytes from undigested cartilage fragments
have the capability to escape from the cartilage matrix
and, by doing so, have an active role in new tissue for-
mation. Whether they can do that in an in vivo situation
under the influence of, for example, endogenous collage-
nases [21, 22], we can just speculate. It seems that when
implanting autologous chondrocytes using fibrin as a
carrier, the results look fairly good [23]. On the other
side, no tissue bonding or new cartilaginous tissue for-
mation has been identified in the cartilage fragments
without enzymatic treatment in a nude mice model [24].
Finally, two studies have shown no cell invasion into the
fibrin matrix [25], as well as direct influence of the pore
size and fibrin strand thickness on the cell invasion [26].
One recently done study has given even more evidence
supporting our results in terms of chondrocyte outgrowth
from adult human articular cartilage [27].
Conclusions
In summary, the results of our in vitro study do not
speak in favor of an early induction of cartilage defect
repair by these techniques using undigested particulated
cartilage fragments embedded in fibrin. However, their
final outcome could be influenced by many endogenous
factors that might be found in an in vivo situation. As
a final conclusion, the use of a fibrin matrix does not
Fig. 4 a Particulated cartilage fragments (stained in brown to the right with S-100) digested overnight with collagenase solution and thereafter
embedded in fibrin matrix (transparent in the middle), ×10 magnification. Bone marrow-originated cells could be visible to the left stained in blue.
These were lying at the upper phase of the perforated nylon membrane, which has been removed during the sample preparation. Both chondrocytes
(marked with white arrow) and bone marrow-originated cells (marked with black arrow) have attached to the fibrin matrix (marked with four-point star)
but have not penetrated it after 5 weeks of cultivation. b Particulated cartilage fragments digested overnight with collagenase solution and thereafter
embedded in fibrin, ×10 magnification. Chondrocytes are stained (marked with arrow) with S-100 and have attached to the fibrin matrix (marked with
four-point stars) but have not penetrated it after 5 weeks of cultivation
Fig. 5 Particulated cartilage fragments digested overnight with
collagenase solution and thereafter embedded in fibrin, eosin
staining, ×40 magnification. Here, we can see bone marrow-originated
cells (marked with arrow) in the lower phase, under the fibrin (marked
with four-point star), and over the perforated nylon membrane (in this
case, it would be found to the right from the cell layer), which has
detached during the sample preparation. No cell invasion after
5 weeks of cultivation
Andjelkov et al. Journal of Orthopaedic Surgery and Research  (2016) 11:23 Page 4 of 5
seem to promote cartilage repair processes due to its
initial inhibition of cell migration, and it seems that
enzymatic digestion of particulated cartilage fragments
is a prerequisite for the chondrocyte migration out of
the cartilage matrix.
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